March 19, 2020 Hope replaces hype for coronavirus stocks Investors are homing in on biopharma companies able to make real contributions to the coronavirus pandemic, but market frothiness is far from over.
March 05, 2020 Biopharma’s role in tackling coronavirus The industry has a duty to develop Covid-19 antivirals and vaccines, but the nature of clinical trials means that lower-profile measures must take precedence.
